PreveCeutical Medical Inc.
PRVCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,187 | $12,832 | $12,648 | $10,140 |
| - Cash | $59 | $1 | $6 | $16 |
| + Debt | $4,461 | $3,894 | $3,292 | $2,929 |
| Enterprise Value | $18,588 | $16,725 | $15,934 | $13,053 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$10 | -$10 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$753 | -$905 | -$1,026 | -$830 |
| % Margin | – | – | – | – |
| Net Income | -$1,175 | -$1,274 | -$1,481 | -$1,727 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.002 | -0.003 | -0.003 |
| % Growth | 8.3% | 14.3% | 17.6% | – |
| Operating Cash Flow | -$427 | -$297 | -$223 | -$426 |
| Capital Expenditures | -$2 | $0 | $0 | -$55 |
| Free Cash Flow | -$428 | -$297 | -$223 | -$482 |